Laura Molteni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura Molteni has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Beatrice Benatti
University of Milan, Department of Mental Health, Department of Biomedical and Clinical Sciences Luigi Sacco, Milan, Italy; "Aldo Ravelli" Center for Neurotechnology and Brain Therapeutic, University of Milan, Milan, Italy
2 shared publications - Harry A. Fagan
University of Southampton
2 shared publications - Nathan Thomas Matthew Huneke
University of Southampton
2 shared publications - Algirdas Midveris
University of Southampton
1 shared publication B. Dell'OSso
Department of Psychiatry, University of Milan, Department of Biomedical and Clinical Sciences "Luigi Sacco", ASST Fatebenefratelli-Sacco, Milan, Italy; Aldo Ravelli" Center for Neurotechnology and Brain Therapeutic, University of Milan, Milan 20142, Italy; Department of Psychiatry, Bipolar Disorders Clinic, Stanford Medical School, Stanford University, Stanford, CA, USA
1 shared publicationB. Dell'Osso
Università degli Studi di Milano, Department of Mental Health- Psychiatry 2 Unit- Luigi Sacco University Hospital, Milano, Italy
1 shared publication
Latest Publications
- Open Access
- 26 September 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e283
Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt
Background: Contemporary society faces significant challenges that can lead to stress-induced tunnel vision. Positive affect can counteract these effects by expanding humans’ attentional scope, potentially promoting resilience and creativity. This preregistered triple-blind study investigated the role of endogenous opioids in mediating attentional broadening following reward receipt. Methods: Using a placebo-controlled crossover design, 40 volunteers underwent two sessions separated by at least 1 week, receiving either 50 mg of naltrexone or a placebo. Participants completed a Navon letters task designed to contrast the effects of reward receipt versus reward anticipation on attentional scope. Results: As predicted, our results show that the attentional broadening observed after reward receipt under placebo was eliminated when opioid receptors were blocked. Naltrexone did not result in blunted reward anticipation effects on task performance or attentional narrowing. Conclusions: This study highlights the role of endogenous opioids in attentional breadth and their potential for cognitive flexibility and resilience through natural positive experiences, with potential implications for mental health and stress management.
- 26 September 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e283
Open AccessSeeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt
Background: Contemporary society faces significant challenges that can lead to stress-induced tunnel vision. Positive affect can counteract these effects by expanding humans’ attentional scope, potentially promoting resilience and creativity. This preregistered triple-blind study investigated the role of endogenous opioids in mediating attentional broadening following reward receipt. Methods: Using a placebo-controlled crossover design, 40 volunteers underwent two sessions separated by at least 1 week, receiving either 50 mg of naltrexone or a placebo. Participants completed a Navon letters task designed to contrast the effects of reward receipt versus reward anticipation on attentional scope. Results: As predicted, our results show that the attentional broadening observed after reward receipt under placebo was eliminated when opioid receptors were blocked. Naltrexone did not result in blunted reward anticipation effects on task performance or attentional narrowing. Conclusions: This study highlights the role of endogenous opioids in attentional breadth and their potential for cognitive flexibility and resilience through natural positive experiences, with potential implications for mental health and stress management.
- Open Access
- 6 April 2024
- Published by Elsevier in Psychiatry Research
- Vol. 336, 115897
Effects of mindfulness-based interventions on symptoms and interoception in trauma-related disorders and exposure to traumatic events: Systematic review and meta-analysis
- 6 April 2024
- Published by Elsevier in Psychiatry Research
- Vol. 336, 115897
Open AccessEffects of mindfulness-based interventions on symptoms and interoception in trauma-related disorders and exposure to traumatic events: Systematic review and meta-analysis
- 30 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, S516
P.0704 Partial response to antidepressant treatment: the role of nutraceutical compounds
- 30 December 2021
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 53, S516
P.0704 Partial response to antidepressant treatment: the role of nutraceutical compounds